Modulation of DNA topoisomerase II activity and expression in melanoma cells with acquired drug resistance

This publication has 18 references indexed in Scilit:

• Expression of DNA repair proteins hMSH2, hMSH6, hMLH1,O6-methylguanine-DNA methyltransferase and N-methylpurine-DNA glycosylase in melanoma cells with acquired drug resistance
  International Journal of Cancer, 1999
• Reduced activity of topoisomerase II in an Adriamycin-resistant human stomach-adenocarcinoma cell line
  Cancer Chemotherapy and Pharmacology, 1998
• A Novel Mutant Topoisomerase II.alpha. Present in VP-16-Resistant Human Melanoma Cell Lines Has a Deletion of Alanine 429
  Biochemistry, 1994
• Mechanism of Action of Topoisomerase II-Targeted Antineoplastic Drugs
  Published by Elsevier ,1994
• Characterization of an unusual mutant of human melanoma cells resistant to anticancer drugs that inhibit topoisomerase II
  Journal of Cellular Physiology, 1993
• Isolation of cDNA clones encoding the β isozyme of human DNA topoisomerase II and localisation of the gene to chromosome 3p24
  Nucleic Acids Research, 1992
• DNA TOPOISOMERASE POISONS AS ANTITUMOR DRUGS
  Annual Review of Biochemistry, 1989
• DNA Topoisomerase Poisons As Antitumor Drugs
  Annual Review of Biochemistry, 1989
• Altered catalytic activity of and DNA cleavage by DNA topoisomerase II from human leukemic cells selected for resistance to VM-26
  Biochemistry, 1988
• Mechanism of antitumor drug action: poisoning of mammalian DNA topoisomerase II on DNA by 4'-(9-acridinylamino)-methanesulfon-m-anisidide.
  Proceedings of the National Academy of Sciences, 1984